PCI Biotech (Norway) Price Prediction
| PCIB Stock | NOK 1.64 0.20 10.87% |
Oversold Vs Overbought
27
Oversold | Overbought |
Using PCI Biotech hype-based prediction, you can estimate the value of PCI Biotech Holding from the perspective of PCI Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in PCI Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying PCI because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
PCI Biotech after-hype prediction price | NOK 1.64 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
PCI |
PCI Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of PCI Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in PCI Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of PCI Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
PCI Biotech Estimiated After-Hype Price Volatility
In the context of predicting PCI Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on PCI Biotech's historical news coverage. PCI Biotech's after-hype downside and upside margins for the prediction period are 0.08 and 8.49, respectively. We have considered PCI Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
PCI Biotech is extremely dangerous at this time. Analysis and calculation of next after-hype price of PCI Biotech Holding is based on 3 months time horizon.
PCI Biotech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as PCI Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PCI Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PCI Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 6.85 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.64 | 1.64 | 0.00 |
|
PCI Biotech Hype Timeline
PCI Biotech Holding is at this time traded for 1.64on Oslo Stock Exchange of Norway. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. PCI is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.01%. %. The volatility of related hype on PCI Biotech is about 0.0%, with the expected price after the next announcement by competition of 1.64. About 32.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PCI Biotech Holding recorded a loss per share of 2.35. The entity had not issued any dividends in recent years. The firm had 405:376 split on the 17th of September 2018. Assuming the 90 days trading horizon the next expected press release will be within a week. Check out PCI Biotech Basic Forecasting Models to cross-verify your projections.PCI Biotech Related Hype Analysis
Having access to credible news sources related to PCI Biotech's direct competition is more important than ever and may enhance your ability to predict PCI Biotech's future price movements. Getting to know how PCI Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how PCI Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| POL | Polaris Media | 0.00 | 0 per month | 2.41 | 0.03 | 3.40 | (3.95) | 17.27 | |
| NTG | Nordic Technology Group | 0.00 | 0 per month | 0.00 | (0.09) | 0.73 | (5.06) | 33.97 | |
| 5PG | 5Th Planet Games | 0.00 | 0 per month | 3.46 | 0 | 6.50 | (5.00) | 25.26 | |
| OTL | Odfjell Technology | 0.00 | 0 per month | 0.00 | (0.12) | 2.84 | (3.64) | 11.24 | |
| GOD | Goodtech | 0.00 | 0 per month | 0.00 | (0.23) | 2.21 | (3.29) | 14.80 | |
| CSS | Clean Seas Seafood | 0.00 | 0 per month | 0.00 | (0.29) | 0.00 | (11.76) | 20.00 | |
| ODL | Odfjell Drilling | 0.00 | 0 per month | 0.00 | (0.10) | 2.84 | (3.90) | 9.31 |
PCI Biotech Additional Predictive Modules
Most predictive techniques to examine PCI price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PCI using various technical indicators. When you analyze PCI charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About PCI Biotech Predictive Indicators
The successful prediction of PCI Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as PCI Biotech Holding, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of PCI Biotech based on analysis of PCI Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to PCI Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PCI Biotech's related companies.
Story Coverage note for PCI Biotech
The number of cover stories for PCI Biotech depends on current market conditions and PCI Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that PCI Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about PCI Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
PCI Biotech Short Properties
PCI Biotech's future price predictability will typically decrease when PCI Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of PCI Biotech Holding often depends not only on the future outlook of the potential PCI Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PCI Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 115.2 M |
Other Information on Investing in PCI Stock
PCI Biotech financial ratios help investors to determine whether PCI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PCI with respect to the benefits of owning PCI Biotech security.